These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Micro-array analysis of the effect of post-transurethral bladder tumor resection urine on transforming growth factor-beta1 dependent gene expression in transitional cell carcinoma. Zhang G; Cao Y; Xu Y; See WA Urol Oncol; 2005; 23(6):413-8. PubMed ID: 16301119 [TBL] [Abstract][Full Text] [Related]
3. [Effects of different expression levels of fibronectin on biological behavior of tumor cells]. Zhang W; Xu Y; Ma T Zhonghua Yi Xue Za Zhi; 1998 Jun; 78(6):430-3. PubMed ID: 10923505 [TBL] [Abstract][Full Text] [Related]
4. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta]. Li Y; Chen N; Yu HJ; Dong XP; Huang QH Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885 [TBL] [Abstract][Full Text] [Related]
5. Regulation of plasminogen activator activity in transitional carcinoma cell lines by wound site growth factors. Xu Y; See WA Surg Oncol; 1994 Jun; 3(3):175-85. PubMed ID: 7952402 [TBL] [Abstract][Full Text] [Related]
6. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells]. Zhang JJ; Wang B Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466 [TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer. Ito M; Nishiyama H; Kawanishi H; Matsui S; Guilford P; Reeve A; Ogawa O J Urol; 2007 Sep; 178(3 Pt 1):1073-9. PubMed ID: 17644138 [TBL] [Abstract][Full Text] [Related]
10. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells]. Li XD; Chen XW; Tang DS; Liang D; Liu HF Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):140-2. PubMed ID: 17286908 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Inoue K; Slaton JW; Kim SJ; Perrotte P; Eve BY; Bar-Eli M; Radinsky R; Dinney CP Cancer Res; 2000 Apr; 60(8):2290-9. PubMed ID: 10786697 [TBL] [Abstract][Full Text] [Related]
13. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628 [TBL] [Abstract][Full Text] [Related]
15. Regulation of fibronectin by thyroid hormone receptors. Lin KH; Chen CY; Chen SL; Yen CC; Huang YH; Shih CH; Shen JJ; Yang RC; Wang CS J Mol Endocrinol; 2004 Oct; 33(2):445-58. PubMed ID: 15525600 [TBL] [Abstract][Full Text] [Related]
16. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region. Inoue T; Nabeshima K; Shimao Y; Koono M Biochem Biophys Res Commun; 1999 Jun; 260(1):225-31. PubMed ID: 10381371 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Suzuki K; Morita T; Tokue A Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Okamoto M; Oyasu R Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901 [TBL] [Abstract][Full Text] [Related]
20. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells. Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]